Literature DB >> 24790889

Concurrence of iridocorneal endothelial syndrome in a patient with glaucomatocyclitic crisis.

Jin A Choi1, Yi Ryeung Park1, Tae Yoon La1.   

Abstract

Entities:  

Year:  2014        PMID： 24790889      PMCID： PMC4003101          DOI： 10.3980/j.issn.2222-3959.2014.02.34

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  8 in total

1.  Detection of herpes simplex virus in aqueous humor in iridocorneal endothelial (ICE) syndrome.

Authors:  M J Groh; B Seitz; S Schumacher; G O Naumann
Journal:  Cornea       Date:  1999-05       Impact factor: 2.651

2.  Cytomegalovirus in aetiology of Posner-Schlossman syndrome: evidence from quantitative polymerase chain reaction.

Authors:  Sc-B Teoh; L Thean; E Koay
Journal:  Eye (Lond)       Date:  2005-12       Impact factor: 3.775

3.  Idiopathic no more: clues to the pathogenesis of Fuchs heterochromic iridocyclitis and glaucomatocyclitic crisis.

Authors:  Russell N Van Gelder
Journal:  Am J Ophthalmol       Date:  2008-05       Impact factor: 5.258

4.  Iridocorneal endothelial syndrome masquerading as iris melanoma in 71 cases.

Authors:  Carol L Shields; Margaret V Shields; Vanessa Viloria; Haley Pearlstein; Emil Anthony T Say; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2011-04-11

5.  A comparison of the clinical variations of the iridocorneal endothelial syndrome.

Authors:  M C Wilson; M B Shields
Journal:  Arch Ophthalmol       Date:  1989-10

6.  Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome.

Authors:  J A Alvarado; J L Underwood; W R Green; S Wu; C G Murphy; D G Hwang; T E Moore; D O'Day
Journal:  Arch Ophthalmol       Date:  1994-12

7.  [Posner-Schlossman syndrome].

Authors:  U Köhler
Journal:  Ophthalmologica       Date:  1992       Impact factor: 3.250

8.  Endothelial cells in the glaucomato-cyclitic crisis.

Authors:  K Setälä; A Vannas
Journal:  Adv Ophthalmol       Date:  1978
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.